Minerva Advisors LLC reduced its position in Kewaunee Scientific Corporation (NASDAQ:KEQU - Free Report) by 32.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 73,765 shares of the technology company's stock after selling 35,728 shares during the quarter. Kewaunee Scientific comprises about 1.8% of Minerva Advisors LLC's holdings, making the stock its 17th largest position. Minerva Advisors LLC owned approximately 2.58% of Kewaunee Scientific worth $2,905,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. IFP Advisors Inc boosted its position in shares of Kewaunee Scientific by 61.5% during the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock worth $37,000 after purchasing an additional 360 shares in the last quarter. Ritholtz Wealth Management boosted its position in shares of Kewaunee Scientific by 42.2% during the 1st quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company's stock worth $707,000 after purchasing an additional 5,330 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after purchasing an additional 443 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Kewaunee Scientific during the 4th quarter worth $300,000. Finally, Marshall Wace LLP purchased a new stake in shares of Kewaunee Scientific during the 4th quarter worth $736,000. 32.69% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Kewaunee Scientific
In related news, CFO Donald T. Gardner III sold 3,000 shares of the business's stock in a transaction dated Thursday, July 24th. The shares were sold at an average price of $58.59, for a total value of $175,770.00. Following the sale, the chief financial officer directly owned 14,564 shares in the company, valued at $853,304.76. The trade was a 17.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 13.30% of the stock is owned by corporate insiders.
Kewaunee Scientific Price Performance
Shares of NASDAQ KEQU opened at $54.78 on Friday. The firm has a market capitalization of $161.60 million, a P/E ratio of 14.30 and a beta of 0.71. Kewaunee Scientific Corporation has a one year low of $30.33 and a one year high of $71.33. The company's fifty day moving average is $48.82 and its two-hundred day moving average is $47.35. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.59 and a current ratio of 2.20.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings data on Wednesday, June 25th. The technology company reported $1.95 EPS for the quarter. Kewaunee Scientific had a net margin of 4.74% and a return on equity of 26.02%. The business had revenue of $77.15 million for the quarter.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th.
View Our Latest Stock Report on KEQU
About Kewaunee Scientific
(
Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
Want to see what other hedge funds are holding KEQU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kewaunee Scientific Corporation (NASDAQ:KEQU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.